Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023: Over 65 Companies Developing Drugs for COPD with Several in Phase III of Testing
05 avr. 2023 04h33 HE
|
Research and Markets
Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
Global Chronic Obstructive Pulmonary Disease Market Size To Grow USD 35.9 Billion By 2030 | CAGR of 8.2%
22 mars 2023 12h30 HE
|
SPHERICAL INSIGHTS LLP
New York, United States, March 22, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Obstructive Pulmonary Disease Market Size to grow from USD 18.20 billion in 2021 to USD 35.90 billion by 2030, at a...
Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott
23 févr. 2023 07h58 HE
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...
Global Chronic Obstructive Pulmonary Disease (COPD) Market Report 2023 - 2028: Featuring AstraZeneca, Pfizer, GlazoSmithKline and Novartis Among Others
23 janv. 2023 10h03 HE
|
Research and Markets
Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company...
Global Chronic Obstructive Pulmonary Disease Markets, Epidemiology and Patient Flow Report 2020-2035: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
14 mai 2021 08h08 HE
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global...